Article

Safety and Efficacy Conerns in the Use of Intravitreal Anti-VEGF Therapy (Sponsored)

This supplement to Ophthalmology Times is sponsored by CME Matters, LLC, and supported by an unrestricted grant from Regeneron Pharmaceuticals, Inc.

 

Safety and Efficacy Conerns in the
Use of Intravitreal Anti-VEGF Therapy

The Historical Perspective on
Efficacy and Systemic Safety


This supplement to Ophthalmology Times is sponsored by CME Matters, LLC, and supported by an unrestricted grant from Regeneron Pharmaceuticals, Inc.
 

 

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.